Cannabis News

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that its subsidiary, Vireo of Charm City, LLC, has signed a definitive agreement to purchase all substantial assets of Charm City Medicus, LLC, a medical cannabis dispensary located in Baltimore, Maryland .

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) is the new parent company of Vireo Health and Green Goods. (PRNewsfoto/Goodness Growth Holdings)

"We are very pleased to be expanding our retail market share in Maryland's medical cannabis market and look forward to introducing our Green Goods™ dispensary brand to the Baltimore area," said Chairman and Chief Executive Officer, Kyle Kingsley , M.D. "With our recent initiatives to expand cultivation and processing capacity in Maryland , we're in an excellent position to continue growing our wholesale and retail sales in the state as our manufacturing capabilities enable us to offer the full spectrum of cannabis products to patients. We also plan to leverage this new location to support engagement activities in the local community through our expungement clinics and other social events."

The Company expects the transaction to close later this year, pending approval of the dispensary license transfer by the Maryland Medical Cannabis Commission. The Company expects total consideration for the transaction at closing of US $8.0 million , including $4.0 million in cash, $2.0 million in Goodness Growth stock, and a $2.0 million promissory note issued to the seller. Goodness Growth shares issued in conjunction with the transaction will be subject to a one-year lock-up agreement. Upon closing of the transaction, the Company expects to transition Charm City to the Green Goods™ brand of retail dispensaries.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, and its science and intellectual property developer, Resurgent Biosciences. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines, and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 17 dispensaries across the United States . For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Contact Information

Investor Inquiries :

Media Inquiries :

Sam Gibbons

Albe Zakes

Vice President, Investor Relations

Vice President, Corporate Communications

samgibbons@vireohealth.com

albezakes@vireohealth.com

(612) 314-8995

(267) 221-4800

Forward-Looking Statement Disclosure

This press release contains "forward-looking information" within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes "financial outlooks" within the meaning of applicable United States or Canadian securities laws, such information is being provided as preliminary financial results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as "plan," "position," "continue," "will," "expects," "pending,"or variations of such words and phrases.  These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management's experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, risks related to current and future economic conditions; risks related to the COVID-19 pandemic; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws in the United States relating to psychedelics  and any changes to such laws; operational, regulatory, and other risks; execution of business strategy; difficulty to forecast; conflicts of interest; liquidity and additional financing; and risk factors set out in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 , which is available on EDGAR with the U.S. Securities and Exchange Commission and filed with the Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com .

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results, or otherwise, other than as required by applicable securities laws.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/goodness-growth-holdings-signs-definitive-agreement-to-acquire-charm-city-medicus-dispensary-in-baltimore-maryland-301328496.html

SOURCE Goodness Growth Holdings

News Provided by PR Newswire via QuoteMedia

Goodness Growth Holdings Launches Cannabis-Infused Gummies in Minnesota

The addition of edibles to Minnesota's medical cannabis program allows for greater choices for certified cannabis patients

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS) (OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the addition of cannabis-infused gummies to its Vireo brand in Minnesota in accordance with Minnesota's new regulations effective Aug. 1 allowing certified medical cannabis patients in the state to purchase certain edible products containing cannabis.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30 th , 2022, on Wednesday, August 17th, 2022, before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cannabis Weekly Round-Up: Tilray Jumps Thanks to Latest Fiscal Results

Cannabis Weekly Round-Up: Tilray Jumps Thanks to Latest Fiscal Results

Shares of Tilray Brands (NASDAQ:TLRY,TSX:TLRY) jumped this week after the company released results for its fourth fiscal quarter and full 2022 year.

Also this past week, a Canadian cannabis producer announced a share consolidation plan.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Curaleaf Celebrates Opening Of Tampa Citrus Park Dispensary

The Company's retail presence grows to 51 locations in the Sunshine State and 137 nationwide

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the opening of its Tampa Citrus Park dispensary, located at 10612 Sheldon Road, Tampa, FL 33626. Curaleaf Tampa Citrus Park expands the Company's retail presence to six locations in Hillsborough County and 51 across the Sunshine State.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

CANOPY GROWTH ANNOUNCES NEW PREMIUM FLOWER LINE-UP PERFECT FOR SUMMER STAYCATIONS AND WEEKENDS AWAY

New premium flower offerings from 7ACRES and Doja drop in retail locations this summer

 Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced several new additions to its premium flower portfolio. Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Bada Bing! The Apothecarium Lodi is Now Open!

Patients and Consumers can now experience the convenience of New Jersey's first Dispensary Drive-Thru

TerrAscend Corp. (" TerrAscend " or the "Company") ( CSE : TER ) (OTCQX: TRSSF ), a leading North American cannabis operator, today announced the opening of The Apothecarium Lodi the Company's third retail location in New Jersey and 27 th overall. The dispensary began medical and adult-use sales today.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×